RNA-binding disturbances as a continuum from spinocerebellar ataxia type 2 to Parkinson disease

Aurore Nkiliza1, Eugénie Mutez2, Clémence Simonin2

  • 1Univ. Lille, UMR-S 1172 - JPArc - Centre de Recherche Jean-Pierre AUBERT Neurosciences et Cancer, F-59000 Lille, France; Inserm, UMR-S 1172, Team "Early stages of Parkinson's disease", F-59000 Lille, France.

Neurobiology of Disease
|September 25, 2016
PubMed

Insights

CAG triplet expansions in the Ataxin-2 gene (ATXN2) are linked to spinocerebellar ataxia type 2 and Parkinson's disease (PD). Transcriptome analysis reveals shared RNA-binding disturbances and decreased ATXN2 protein in patients, suggesting a continuum between these neurological disorders.

Area of Science:

  • Neurogenetics
  • Molecular Biology
  • Transcriptomics

Background:

  • CAG triplet expansions in the Ataxin-2 gene (ATXN2) are causative for spinocerebellar ataxia type 2 (SCA2c).
  • The role of ATXN2 expansions in Parkinson's disease (PD) remains unclear.
  • Investigating molecular pathways in SCA2c and PD patients with and without ATXN2 expansions is crucial.

Purpose of the Study:

  • To analyze transcriptome profiles of blood cells from controls and patients with SCA2c or PD (with/without ATXN2 expansions).
  • To identify molecular events and pathways associated with ATXN2 expansions in neurological disorders.
  • To explore potential commonalities and differences in molecular dysfunctions between SCA2c and PD.

Main Methods:

  • Sequencing of ATXN2 CAG triplet repeats.
  • Transcriptome analysis of blood cells from 40 individuals (controls, SCA2c, PD with ATXN2 expansions [SCA2p], sporadic PD).
  • Analysis of gene and pathway alterations, including RNA metabolism and protein expression.

Main Results:

  • SCA2p patients showed distinct pathways related to cellular contacts, proliferation, and differentiation.
  • Similarities in altered genes/pathways (Wnt, Ephrin, Leukocyte extravasation) were observed between SCA2p and sporadic PD.
  • Common RNA metabolism disturbances (RNA-binding, poly(A) RNA-binding) were found across all patient groups.
  • Shared ALS signaling pathway disturbances between SCA2p and sporadic PD suggest common molecular dysfunctions.
  • Decreased ATXN2 protein expression was observed in SCA2c and SCA2p patients, despite normal RNA expression.
  • Transcriptome profiles indicated prevalent translation alterations in parkinsonian phenotypes and splicing perturbations in SCA2c and PD patients.

Conclusions:

  • Transcriptome data do not exclude a role for mutated ATXN2 alleles in PD.
  • Decreased ATXN2 protein expression in SCA2c and SCA2p patients suggests a potential involvement of ATXN2 in PD.
  • RNA-binding disturbances represent a potential continuum between SCA2c and PD, highlighting shared molecular mechanisms.

Related Concept Videos

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.3K
Neural Regulation01:37

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
44.0K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.3K
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining,...
12.6K
Alternative RNA Splicing02:18

Alternative RNA Splicing

Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
25.9K
Translation01:31

Translation

Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Proteins are...
21.5K